Therapeutic targeting in the silent era: advances in non-viral siRNA delivery
- 29 April 2010
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Molecular BioSystems
- Vol. 6 (7), 1143-1161
- https://doi.org/10.1039/c001050m
Abstract
Gene silencing using RNA-interference, first described in mammalian systems almost a decade ago, is revolutionizing therapeutic target validation efforts both in vitro and in vivo. Moreover, the potential for using short interfering RNA (siRNA) as a therapy in its own right is also progressing at a significant pace. However, the widespread use of such approaches is contingent on having appropriate systems to achieve clinically appropriate, safe, and efficient delivery of siRNA. There are many physicochemical and biological barriers to such delivery, and a growing emphasis on the design and characterisation of non-viral technologies that will overcome these barriers and expedite targeted delivery. This review discusses the considerations and challenges associated with use of siRNA-based therapeutics, including stability and off-target effects. Speculation is made on the properties of an ideal delivery system and the non-viral delivery approaches used to date, both in vitro and in vivo, are classified and discussed. Moreover, the ability of cyclodextrin-based delivery vectors to fulfil many of the criteria of an ideal delivery construct is also elaborated.Keywords
This publication has 97 references indexed in Scilit:
- Biological Barriers to Therapy with Antisense and siRNA OligonucleotidesMolecular Pharmaceutics, 2009
- Novel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer CellsMolecular Pharmaceutics, 2009
- Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenitaJournal of Dermatological Science, 2008
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNAMolecular Therapy, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cellsExperimental Hematology, 2008
- Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticlesJournal of Controlled Release, 2008
- Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing NanoparticlesBioconjugate Chemistry, 2007
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006